Radioembolization with yttrium-90 microspheres for the management of uveal melanoma liver metastases a review of clinical effectiveness and cost-effectiveness
A 2015 CADTH Rapid Response report identified systematic reviews, meta-analyses, and economic evaluations on the clinical and cost-effectiveness of yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver cancer, but no evidence on uveal melanoma liver metastasis was...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
2018, August 30, 2018
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | A 2015 CADTH Rapid Response report identified systematic reviews, meta-analyses, and economic evaluations on the clinical and cost-effectiveness of yttrium-90 microsphere radioembolization for the treatment of primary or secondary liver cancer, but no evidence on uveal melanoma liver metastasis was found. With increasing interest in comparing the impact of selective internal radiotherapy with radioisotopes (SIRT) to other treatment therapies such as transarterial chemoembolization (TACE), this Rapid Response report aims to review the comparative clinical and cost-effectiveness of radioembolization with yttrium-90 microspheres versus other options for the treatment of adult patients with uveal melanoma liver metastasis |
|---|---|
| Physical Description: | 1 PDF file (11 pages) illustrations |